• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Men's Health  • Men's Health, Other  • Dry Eye Syndromes  • Alert me on articles by topic  Social Bookmarking   What's this?

Estimates From the Physicians' Health Studies

Debra A. Schaumberg, ScD, OD, MPH; Reza Dana, MD, MPH; Julie E. Buring, ScD; David A. Sullivan, PhD

Arch Ophthalmol. 2009;127(6):763-768.

Objective  To estimate the prevalence and risk factors for dry eye disease (DED) among US men.

Methods  Cross-sectional prevalence survey among male participants 50 years and older in the Physicians' Health Studies I (N = 18 596) and II (N = 6848). We defined DED as the presence of clinically diagnosed dry eye or severe symptoms (both dryness and irritation constantly or often). We calculated the age-standardized prevalence of DED adjusted to the age distribution of US men in 2004 and projected estimates forward to 2030. We compared DED prevalence with a similar cohort of women and examined associations with possible risk factors.

Results  The prevalence of DED increased with age, from 3.90% among men aged 50 to 54 years to 7.67% among men 80 years and older (P for trend <.001). High blood pressure (odds ratio, 1.28; 95% confidence interval, 1.12-1.45) and benign prostatic hyperplasia (odds ratio, 1.26; 95% confidence interval, 1.09-1.44) were associated with a higher risk of DED. Use of antidepressants, antihypertensives, and medications to treat benign prostatic hyperplasia were also associated with increased risk of DED. The age-standardized prevalence of DED was 4.34%, or 1.68 million men 50 years and older, and is expected to affect more than 2.79 million US men by 2030.

Conclusions  Dry eye disease is prevalent and increases with age, hypertension, benign prostatic hyperplasia, and antidepressant use.

Author Affiliations: Division of Preventive Medicine, Brigham and Women's Hospital (Drs Schaumberg and Buring), the Schepens Eye Research Institute (Drs Schaumberg, Dana, and Sullivan), and the Massachusetts Eye and Ear Infirmary, Department of Ophthalmology (Dr Dana), Harvard Medical School, Boston, Massachusetts.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Epithelial-Mesenchymal Transition in Repair of the Lacrimal Gland after Experimentally Induced Injury
You et al.
IOVS 2012;53:126-135.
ABSTRACT | FULL TEXT  

Dry Eye Disease: An Immune-Mediated Ocular Surface Disorder
Stevenson et al.
Arch Ophthalmol 2012;130:90-100.
ABSTRACT | FULL TEXT  

Rasch Analysis of the Ocular Surface Disease Index (OSDI)
Dougherty et al.
IOVS 2011;52:8630-8635.
ABSTRACT | FULL TEXT  

Ocular Mucin Gene Expression Levels as Biomarkers for the Diagnosis of Dry Eye Syndrome
Corrales et al.
IOVS 2011;52:8363-8369.
ABSTRACT | FULL TEXT  

Interferon-{gamma}-secreting NK cells promote induction of dry eye disease
Chen et al.
J. Leukoc. Biol. 2011;89:965-972.
ABSTRACT | FULL TEXT  

Prevalence of Dry Eye Disease in an Elderly Korean Population
Han et al.
Arch Ophthalmol 2011;129:633-638.
ABSTRACT | FULL TEXT  

Changes in Gene Expression in Human Meibomian Gland Dysfunction
Liu et al.
IOVS 2011;52:2727-2740.
ABSTRACT | FULL TEXT  

The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Anatomy, Physiology, and Pathophysiology of the Meibomian Gland
Knop et al.
IOVS 2011;52:1938-1978.
FULL TEXT  

The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGD
Schaumberg et al.
IOVS 2011;52:1994-2005.
FULL TEXT